Form 4: Vaxcyte Executive Reports Stock Transaction
Insider Transaction (Form 4)
Harpreet S. Dhaliwal, Chief Technical Ops Officer of Vaxcyte, Inc., reported multiple transactions in common stock on August 31, 2026.
Summary
- Tax/exercise-price withholding: disposed of 361 Common Stock at $60.74 ($21,927) on August 31, 2026; holds 76,395 after (Direct).
- Tax/exercise-price withholding: disposed of 659 Common Stock at $61.58 ($40,581) on September 2, 2026; holds 75,736 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Harpreet S. Dhaliwal — Officer (Chief Technical Ops Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-31 | Tax/exercise-price withholding | Common Stock | 361 | $61 | $21.9K | 76,395 |
| 2026-09-02 | Tax/exercise-price withholding | Common Stock | 659 | $62 | $40.6K | 75,736 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-31 | Tax/exercise-price withholding (361 shares) |
| 2026-09-02 | Tax/exercise-price withholding (659 shares) |
Keywords
insider transaction, Form 4, PCVX, Vaxcyte, Inc., neutral, Harpreet S. Dhaliwal
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.